# OnCo record idea-total-body-pet-dosimetry (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-total-body-pet-dosimetry/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-total-body-pet-dosimetry" ;
  schema:name "Total-body PET for personalised radioligand dosing"@en ;
  schema:description "Ultra-sensitive whole-body scanners can measure exactly where a radioactive drug goes at tiny tracer doses, allowing each patient's therapeutic dose to be tailored."@en ;
  schema:url <https://onco.cc/ideas/idea-total-body-pet-dosimetry/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2107322> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/spect/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/> ;
  onco:companies <https://onco.cc/companies/united-imaging/>, <https://onco.cc/companies/siemens-healthineers/> ;
  onco:terms <https://onco.cc/terms/dosimetry/> ;
  onco:trials <https://onco.cc/trials/nct06004661/>, <https://onco.cc/trials/psmaddition/>, <https://onco.cc/trials/psmafore/>, <https://onco.cc/trials/therap/>, <https://onco.cc/trials/vision/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-oncol-ther-2025/>, <https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-journal-2023/> .